Chronic and Integrated Care
We’re building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes.
Program Leaders
Our Chronic and Integrated Care Program Leaders are supported by nine Chronic and Integrated Care Program Group Leaders and a team of more than 40 group members. View a full listing of Chronic and Integrate Program researchers.
Program Groups
Diabetes and Metabolism Research
Genetics, Genomics and Transcriptomics Research
Immunopathology Research
Infection, Immunity and Metabolism Research
Inflammatory Bowel Disease Research
Innate Immunity and Inflammation
Macrophage Biology Research
Musculoskeletal Genomics Group
Respiratory and Infectious Diseases Research
Stem Cell Biology Research
Clinical Trials
Clinical trials are an essential component of modern healthcare and provide evidence to evaluate the safety and efficacy of new treatments, diagnostics and health interventions and offer alternative options for patients with unmet needs under current standards of care. Explore Chronic and Integrated Care clinical trials currently running at Mater Research below or learn more about Mater Clinical Trials.
-
VAV00039 - a vaccine to protect against RSV
-
A new oral treatment for patients with Pulmonary Fibrosis
-
A potential new oral treatment for UC
-
A potential new treatment for Eosinophilic Esophagitis (EoE)
-
A potential new treatment for ulcerative colitis (ATLAS-UC)
-
A study looking at bowel healing for patients
-
A Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)
-
ABTECT-1
-
ARORAGE-100
-
Assessment of airway clearance techniques in adults with bronchiectasis
-
Celgene
-
CIC-E-301: a potential new combination vaccine for COVID-19 and flu
-
CROSSING
-
Do you have celiac disease and are on a gluten free diet?
-
ElevAAte
-
EMERALD2
-
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial – 1)
-
FUZION
-
Nimble
-
PACIFIC-9
-
Palekona
-
Pilaster
-
QUASAR Jr
-
SNDX-6352-0506
-
SPECIFI-CD - A potential new treatment for Crohn's Disease (CD)
-
Teton 2
-
UPlift
